MARKET INSIGHTS
The Global (S)-2-Pentanol market was valued at USD 28.4 million in 2025. The next year saw a rise to USD 29.8 million, and the projection for 2034 reaches USD 46.2 million, reflecting a steady expansion over the forecast period.
(S)-2-Pentanol is a chiral secondary alcohol distinguished by its specific stereochemical configuration at the second carbon. It serves as a pivotal building block and chiral auxiliary in asymmetric synthesis, pharmaceutical intermediates, and fine chemical production. Its moderate volatility, compatibility with organic solvents, and defined stereopurity make it especially suitable for flavors, fragrances, solvent formulations, and specialty chemical synthesis.
Demand for enantiomerically pure compounds in the pharmaceutical and agrochemical sectors is the main driver of market growth. The focus on stereochemical precision directly influences biological activity and regulatory compliance. Growing investments in chiral chemistry and expanding applications in aroma chemical production further reinforce momentum. Leading manufacturers such as TCI Chemicals, Alfa Aesar, and Sigma‑Aldrich (Merck KGaA) supply high‑purity grades for both research and industrial‑scale needs.
(S)-2-Pentanol Market – View in Detailed Research Report
Top 10 Companies in the (S)-2-Pentanol Market
10. Merck KGaA
Headquarters: Darmstadt, Germany
Key Offering: High‑volume commercial quantities of (S)-2‑Pentanol with consistent quality control via Sigma‑Aldrich.
Merck KGaA’s extensive R&D in asymmetric catalysis and biocatalysis underpins its leadership in chiral intermediates. The company’s integrated production sites ensure reliable supply for pharmaceutical and fine‑chemical applications.
Sustainability Initiatives: Commitment to reducing carbon footprints through process optimization and renewable feedstock usage.
- Advanced chiral resolution techniques.
- Partnerships with CDMOs for scalable production.
- Investment in renewable biocatalytic platforms.
9. BASF SE
Headquarters: Ludwigshafen, Germany
Key Offering: Fine‑chemical‑grade (S)-2‑Pentanol for pharmaceuticals, flavors, and agrochemicals.
BASF’s robust R&D and global supply network position it as a key supplier in the niche chiral alcohol market.
Sustainability Initiatives: Focus on green chemistry and energy‑efficient manufacturing.
- Process intensification to lower energy use.
- Integration of bio‑derived feedstocks.
- Transparent sustainability reporting.
8. Tokyo Chemical Industry (TCI)
Headquarters: Tokyo, Japan
Key Offering: Custom synthesis of research‑grade (S)-2‑Pentanol.
TCI’s expertise in chiral synthesis and rapid turnaround supports academic and industrial projects requiring high‑purity intermediates.
Sustainability Initiatives: Emphasis on efficient laboratory‑scale production and waste minimization.
- Use of recyclable catalysts.
- Optimized solvent recovery.
- Support for green chemistry initiatives.
7. Codexis Inc.
Headquarters: Emeryville, USA
Key Offering: Biocatalytic production of (S)-2‑Pentanol at commercial scale.
Codexis leverages engineered enzymes to deliver cost‑competitive, high‑enantiomeric‑excess products.
Sustainability Initiatives: Development of continuous‑flow bioprocesses to reduce waste.
- Immobilized enzyme platforms.
- Cofactor recycling systems.
- Low‑energy downstream purification.
6. Thermo Fisher Scientific
Headquarters: Waltham, USA
Key Offering: High‑purity (S)-2‑Pentanol for research and industrial applications.
Thermo Fisher’s global reach and analytical capabilities support quality assurance for chiral intermediates.
Sustainability Initiatives: Commitment to reducing chemical waste and improving resource efficiency.
- Closed‑loop solvent systems.
- Energy‑efficient manufacturing.
- Transparent environmental metrics.
5. Advanced Biotech Inc.
Headquarters: San Francisco, USA
Key Offering: Flavor‑grade (S)-2‑Pentanol with a focus on natural aroma profiles.
Advanced Biotech supplies the fragrance and food industries with chiral alcohols that enhance sensory experience.
Sustainability Initiatives: Use of renewable raw materials and low‑toxic production routes.
- Biocatalytic synthesis from renewable feedstocks.
- Reduced solvent usage.
- Eco‑friendly packaging solutions.
4. Penta International
Headquarters: New York, USA
Key Offering: Fragrance‑grade (S)-2‑Pentanol with precise odor characteristics.
Penta International’s expertise lies in delivering high‑quality aroma chemicals to the cosmetics and personal‑care sectors.
Sustainability Initiatives: Focus on green chemistry and responsible sourcing.
- Zero‑waste manufacturing.
- Renewable energy use.
- Supply‑chain transparency.
3. Vigon International
Headquarters: Boston, USA
Key Offering: Specialty‑grade (S)-2‑Pentanol for advanced chemical synthesis.
Vigon’s tailored solutions cater to niche research and development projects requiring strict stereochemical control.
Sustainability Initiatives: Commitment to reducing environmental impact through process innovation.
- High‑yield catalytic processes.
- Low‑energy consumption.
- Comprehensive waste‑reduction programs.
2. Alfa Aesar
Headquarters: Haverhill, USA
Key Offering: Research‑grade (S)-2‑Pentanol for academic and industrial laboratories.
Alfa Aesar provides a broad portfolio of chiral reagents, supporting the development of new pharmaceuticals and fine chemicals.
Sustainability Initiatives: Adoption of greener synthesis routes and responsible packaging.
- Biocatalytic production pathways.
- Eco‑friendly shipping options.
- Carbon‑neutral logistics.
1. Evonik Industries AG
Headquarters: Essen, Germany
Key Offering: High‑purity (S)-2‑Pentanol for pharmaceutical intermediates and specialty chemicals.
Evonik’s extensive experience in fine‑chemical manufacturing positions it as a reliable source for chiral intermediates.
Sustainability Initiatives: Integration of circular economy principles and renewable energy.
- Process recycling of solvents.
- Renewable feedstock utilization.
- Transparent sustainability reporting.
Market Outlook
The trajectory of the (S)-2-Pentanol market indicates a consistent rise in demand, driven by the expansion of pharmaceutical R&D pipelines and the need for high‑purity chiral intermediates. By 2034, the market is expected to reach USD 46.2 million, reflecting a robust upward trend over the next decade.
Future Trends
Key trends shaping the market include the rapid adoption of biocatalytic production methods, which offer lower cost and higher sustainability compared to traditional resolution techniques. The growing pipeline of chiral drug candidates across therapeutic areas—such as central nervous system disorders, oncology, and anti‑infective agents—will further elevate demand for enantiomerically pure intermediates. Additionally, the push toward green chemistry principles is encouraging the development of bio‑derived (S)-2‑Pentanol, positioning it as a preferred choice for manufacturers prioritizing environmental performance alongside regulatory compliance.
- Top 10 Companies in the Micro Powder Silymarin Market (2026): Market Leaders Powering Global Health - October 14, 2026
- Top 10 Companies in the PVD Coating for Automotive Interior and Exterior Market (2026): Market Leaders Powering Global Automotive Aesthetics - October 14, 2026
- Top 10 Companies in the Latin America Testliner (Recycled Paperboard) Market (2026): Market Leaders Driving Sustainable Packaging - October 14, 2026
